CLB · XBRL financial data

Core Laboratories financial statements, every fiscal year

The same tables from 3 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (CLB's year ends in late December)

In thousands of dollars	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue from contracts with customers	509,790	523,848	526,520
Cost of goods and services sold	399,957	420,522	417,587
General and administrative	40,259	39,770	45,430
Other operating income (expense)	850	9,953	7,614
Operating income (loss)	54,640	58,556	56,468
Interest expense	13,430	12,369	10,572
Other income (expense)	(850)	9,953	7,614
Income tax expense (benefit)	(4,185)	14,034	15,505
Net income (loss)	36,675	31,400	29,669
Earnings per share, basic USD per share	0.79	0.67	0.64
Earnings per share, diluted USD per share	0.77	0.66	0.63
Weighted average shares, basic thousands of shares	46,683	46,897	46,427
Weighted average shares, diluted thousands of shares	47,523	47,685	47,028

Fiscal years (CLB's year ends in late December)

In thousands of dollars	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	15,120	19,157	22,702
Accounts receivable	109,352	111,761	113,528
Inventory	71,702	59,402	54,496
Total current assets	223,136	226,606	214,665
Property and equipment, net	99,626	97,063	99,447
Right-of-use asset	53,842	56,488	54,346
Goodwill	99,445	99,445	105,789
Total assets	586,395	590,406	584,010
Accounts payable	33,506	34,549	37,275
Total current liabilities	88,097	97,586	106,015
Long-term debt	163,134	126,111	110,255
Lease liability, non-current	42,076	43,343	42,309
Retained earnings	120,756	150,280	172,662
Total stockholders' equity	224,815	251,991	265,986
Total liabilities and equity	586,395	590,406	584,010
Common shares outstanding (cover page) thousands of shares	46,857	46,827	46,050

Fiscal years (CLB's year ends in late December)

In thousands of dollars	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	36,675	31,400	29,669
Stock-based compensation	13,971	3,755	7,137
Depreciation and amortization	15,784	14,953	14,649
Net cash from operating activities	24,789	56,388	37,031
Purchases of property and equipment	10,579	13,028	11,209
Net cash from investing activities	(6,652)	(6,394)	(2,231)
Proceeds from issuing common stock	0	—	—
Share repurchases	2,202	5,306	12,426
Dividends paid	1,868	1,876	1,869
Proceeds from long-term debt	202,000	44,000	48,000
Repayments of long-term debt	211,000	82,000	63,000
Net cash from financing activities	(18,445)	(45,957)	(31,255)

The peer list for this company is being put together from its industry's latest filings. Reload the page in a minute to see it.

Not investment advice. Not affiliated with the U.S. SEC.